CIPROFLOXACIN THERAPY FOR MEDITERRANEAN SPOTTED-FEVER

被引：36

作者：

RAOULT, D

GALLAIS, H

DEMICCO, P

CASANOVA, P

机构：

[1] HOP SALVADOR MARSEILLE,BACTERIOL LAB,F-13009 MARSEILLE,FRANCE

[2] HOP F HOUPHOUET BOIGNY,INFECT DIS UNIT,F-13015 MARSEILLE,FRANCE

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1986年 / 30卷 / 04期

关键词：

D O I：

10.1128/AAC.30.4.606

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：606 / 607

页数：2

共 6 条

[1]

FONTCREUS B, 1985, REV INFECT DIS, V7, P635

[2] PHARMACOKINETICS OF CIPROFLOXACIN AFTER ORAL AND PARENTERAL ADMINISTRATION [J].

HOFFKEN, G ;

LODE, H ;

PRINZING, C ;

BORNER, K ;

KOEPPE, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :375-379

[3] INVITRO SUSCEPTIBILITY OF RICKETTSIA-CONORII TO CIPROFLOXACIN AS DETERMINED BY SUPPRESSING LETHALITY IN CHICKEN EMBRYOS AND BY PLAQUE-ASSAY [J].

RAOULT, D ;

ROUSSELLIER, P ;

GALICHER, V ;

PEREZ, R ;

TAMALET, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :424-425

[4] MEDITERRANEAN SPOTTED-FEVER - CLINICAL, LABORATORY AND EPIDEMIOLOGIC FEATURES OF 199 CASES [J].

RAOULT, D ;

WEILLER, PJ ;

CHAGNON, A ;

CHAUDET, H ;

GALLAIS, H ;

CASANOVA, P .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (04) :845-850

[5]

RAOULT D, 1983, PRESSE MED, V12, P2375

[6]

SANDE MA, 1980, PHARM BASIS THERAPEU, P1193

← 1 →